+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus

Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus

Neuroreport 13(16): 2031-2033

The amyloid cascade hypothesis suggests that amyloid precursor protein (APP) proteolytic processing is a key event in the pathogenesis of Alzheimer's disease (AD). The enzymes beta-site APP cleaving enzyme (BACE) and A disintegrin and metalloproteinase 10 (ADAM10) play an important role in APP proteolysis. We measured by real time quantitative polymerase chain reaction their mRNA levels in hippocampal and cerebellar sections from 13 AD and 12 control brains. BACE mRNA amounts were similar in patients and controls. In contrast, ADAM10 mRNA levels were twofold higher in AD samples, but without relationship to the severity of anatomical damage. The data do not support the hypothesis that alteration of BACE and ADAM10 expression are associated with development of late stages of AD.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 010920085

Download citation: RISBibTeXText

PMID: 12438920

Related references

Levels of ??-secretase Bace and ??-secretase Adam10 mRnas in Alzheimer hippocampus. NeuroReport 13(16): 2031-2033, 2002

Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. Journal of Neurochemistry 75(5): 2133-2143, 2000

Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease. Brain Research. Molecular Brain Research 116(1-2): 155-158, 2003

Identification of a novel substrate of Alzheimer's beta-secretase: beta-secretase dependent cleavage of alpha 2,6 sialyltransferase. Seikagaku. Journal of Japanese Biochemical Society 74(9): 1180-1183, 2002

Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease. Neurobiology of Aging 32(3): 541-543, 2011

Beta-secretase (BACE) as a drug target for Alzheimer's disease. Advanced Drug Delivery Reviews 54(12): 1589-1602, 2002

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment. Pharmaceuticals 11(1), 2018

alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Molecular Medicine 8(2): 67-74, 2002

The beta-secretase, BACE: a prime drug target for Alzheimer's disease. Journal of Molecular Neuroscience 17(2): 157-170, 2002

A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase. Journal of Biological Chemistry 275(48): 37712-7, 2000

Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease. Neuroscience Letters 313(1-2): 105-107, 2001

Take Five: BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO (European Molecular Biology Organization) Journal 23(3): 483-488, 11 February, 2004

Beta-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (Washington D C) 286(5440): 735-741, Oct 22, 1999

Heparin derivatives as inhibitors of BACE-1, the Alzheimer's beta-secretase, with reduced activity against factor Xa and other proteases. Journal of Medicinal Chemistry 49(20): 6129-6132, 2006

Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties. Journal of Biological Chemistry 275(28): 21099-21106, 2000